Trial · NCT03408730
Results by group45
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 45
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Geometric Mean Concentration (GMC) of Anti-HBs at Day 196 for Lot-to-Lot Consistency (Per Protocol Set 1) | Sci-B-Vac Lot A Hep B Vaccination | 5883.93 | Standard Deviation 5.423 | mIU/ml | |
| Geometric Mean Concentration (GMC) of Anti-HBs at Day 196 for Lot-to-Lot Consistency (Per Protocol Set 1) | Sci-B-Vac Lot B Hep B Vaccination | 4824.06 | Standard Deviation 6.293 | mIU/ml | |
| Geometric Mean Concentration (GMC) of Anti-HBs at Day 196 for Lot-to-Lot Consistency (Per Protocol Set 1) | Sci-B-Vac Lot C Hep B Vaccination | 5505.98 | Standard Deviation 5.975 | mIU/ml | |
| Seroprotection Rate (SPR) of Anti-HBs at Day 196 for Sci-B-Vac® Compared to Day 196 for Engerix-B® (Per Protocol Set 2) | Comparator: ENGERIX-B Hep B Vaccination | 561 | Participants | ||
| Seroprotection Rate (SPR) of Anti-HBs at Day 196 for Sci-B-Vac® Compared to Day 196 for Engerix-B® (Per Protocol Set 2) | Pooled Sci-B-Vac® | 1740 | Participants | ||
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Comparator: ENGERIX-B Hep B Vaccination | Pain | 384 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot A Hep B Vaccination | Pain | 527 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot B Hep B Vaccination | Pain | 536 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot C Hep B Vaccination | Pain | 542 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Comparator: ENGERIX-B Hep B Vaccination | Tenderness | 391 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot A Hep B Vaccination | Tenderness | 519 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot B Hep B Vaccination | Tenderness | 535 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot C Hep B Vaccination | Tenderness | 541 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Comparator: ENGERIX-B Hep B Vaccination | Pruritis/itching | 88 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot A Hep B Vaccination | Pruritis/itching | 84 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot B Hep B Vaccination | Pruritis/itching | 105 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot C Hep B Vaccination | Pruritis/itching | 92 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Comparator: ENGERIX-B Hep B Vaccination | Redness/erythema | 12 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot A Hep B Vaccination | Redness/erythema | 27 | Participants | |
| Percentage of Subject-reporting Solicited Local and Systemic Adverse Events (AEs) | Sci-B-Vac Lot B Hep B Vaccination | Redness/erythema | 20 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03408730/results